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SHORT REPORT
Prognostic factors in patients with salivary gland malignancy: a retrospective
cohort study
Moghira Iqbaluddin Siddiqui1, Haissan Iftikhar2, Umar Farooq Bhatti3, Mubasher Ikram4

Abstract
Our objective was to determine the factors aﬀecting the
prognosis in patients with major salivary gland malignancy
presenting to Aga Khan University Hospital in Karachi.
Retrospective cohort study was carried out at our center
on patients diagnosed and treated for salivary gland
cancers. Presentation and treatment oﬀered was reviewed
from medical charts. Telephonic interviews were
conducted to assess the survival of patients who were lost
to follow-up. Log rank test was used to compare the mean
survival times. A total of 36 patients were included in the
study. The mean age was 45.1 +/- 14.6 years. Majority were
male 21 (58.3%). The most common malignancy was
mucoepidermoid carcinoma (36.1%) followed by adenoid
cystic carcinoma (22.2%). Node positivity, grade of tumor,
radiotherapy and chemotherapy were a signiﬁcant
indication of survival times on log rank test.
Keywords: Salivary gland malignancy, survival time,
prognostic factors.
DOI: https://doi.org/10.5455/JPMA.21512

Introduction
Salivary gland malignancies are a heterogeneous group of
tumours that have varying biological behaviours. These
tumours comprise 3-10% of all head and neck
malignancies.1 The global annual incidence varies between
0.05 – 2/100,000.1 The incidence of major salivary gland
malignancies increases with age; the overall incidence is
rare for below 40 years of age.1 Males are more often
aﬀected than females.1 Malignancy of salivary gland is
uncommon and therefore there are few prospective studies
on the subject.2 Exact cause of Salivary gland neoplasms is
unknown.3 Low intake of cholesterol has shown to have a
protective role.4 Intake of dark yellow vegetables and liver
also showed to reduce risk of salivary gland neoplasms.5
There is a knowledge gap regarding the behaviour and
survival of patients suﬀering from salivary gland
malignancy in our population. Studies have shown
diﬀerence in survival with grade of tumour6 and type of
tumour.7,8 Advanced radiation therapy techniques like
IMRT have shown survival beneﬁts.9,10 We hypothesized
1,2,4Department of Surgery, Aga Khan University Hospital, Karachi Pakistan;
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that the prognostic factors diﬀer in our cohort of patients
than those reported in the West.

Material Methods and Results
A retrospective cohort study was conducted at Aga Khan
University Hospital Karachi Pakistan. Prior to the
commencement of our survey, approval was obtained from
the institutional ethical review committee. All the patients
who were treated for a salivary gland malignancy from
January 1, 2005 to December 31, 2015 were reviewed for
the study. The data was obtained from a prospectively
maintained database. The data were collected by a
qualiﬁed and trained data collector. Patient demographics,
tumour and treatment related variables were obtained
from medical charts using a proforma. Information on the
overall survival was obtained by telephonic interview of the
patients who were lost to follow up. Patients that had a
salivary gland malignancy on ﬁnal histopathology and who
were over the age of 18 years were included for the
analysis. Those with benign lesions; those who received
prior treatment before presentation at our institute, and
those with distant metastasis at the time of arrival were
excluded. Patients with incomplete records, and those who
did not complete their treatment were also excluded from
the study.
The data was analyzed using STATA version 12. Continuous
variables are reported with mean ± standard deviation and
categorical variables are reported with frequencies and
percentages. Survival analysis was done using cox
proportional hazard ratio and Kaplan Meier curves drawn
to graphically illustrate the survival proportion.
Schoenfeld's global test was used to assess if the data
fulﬁlled the assumption of proportionality. A total of 36
patients matched the eligibility criteria. The mean age of
the patients was 45.08 ± 14.57 years and the majority were
male 21 (58.3%). The most common site of malignancy was
the parotid gland 31 (58.3%). The ﬁne needle aspiration
cytology revealed malignancy in 12 cases (33.3%). Final
histopathology reported mucoepidermoid carcinoma in 13
cases (36.1%) followed by adenoid cystic carcinoma in 8
cases (22.2%); 5 cases of Acinic cell carcinoma (13.9%), 3 of
squamous cell carcinoma (8.3%) and a small proportion of
other malignancies were also reported. Table-1.
Majority of the cases 19 (52.8%) were reported as high
J Pak Med Assoc
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Table-1: Patient demographics, tumour and treatment variables with respect to
survival status.
Variable
Outcome status
Alive
Event
(Dead)
Mean ± SD (Continuous)
Frequencies n (%) (Categorical)

Table-2: Mean survival time (months) and log rank test.
Variable
Category
Mean survival time
(Months)

Age
Gender

FNAC

Male
Female
Site
Parotid gland
Submandibular gland
FNAC
Positive
Negative
Final histopathology Mucoepidermoid
Adenoid cystic
Acinic cell
Squamous cell carcinoma
Lymphoepithelial
carcinoma
Salivary duct carcinoma
Adenocarcinoma
Carcinoma ex pleomorphic
Poorly differentiated ca
Tumor Grade
Low/Intermediate
High
Neck dissection
Yes
No
Node positivity
Yes
No
Surgery
Parotidectomy
Parotidectomy + Neck
Dissection
Submandibular gland excision
Submandibular gland excision
+ Neck dissection
Radiotherapy
Yes
No
Chemotherapy
Yes
No

45.1 ± 14.6
16 (76.19)
5 (23.81)
12 (80)
3 (20)
25 (80.65)
6 (19.35)
3 (60)
2 (40)
9 (75)
3 (25)
19 (71.17)
5 (20.83)
10 (76.92)
3 (23.08)
6 (75)
2 (25)
5 (100)
0
1 (33.33)
2 (66.67)
1 (100)

0

0
1 (100)
2 (100)
17 (100)
11 (57.89)
13 (61.90)
15 (100)
5 (41.67)
23 (95.83)
11 (100)
13 (68.42)

1 (100)
0
0
0
8 (42.11)
8 (38.10)
0
7 (58.33)
1 (4.17)
0
6 (31.58)

3 (100)
1 (33.33)

0
2 (66.67)

14 (66.67)
14 (93.33)
1 (33.33)
27 (81.82)

7 (33.33)
1 (6.67)
2 (66.67)
6 (18.18)

grade on ﬁnal histopathology while 12 cases as low or
intermediate grade (47.2%). Neck dissection was carried
out on 21 cases (58.3%) due to clinical or radiological
suspicion of malignancy, 12 cases (57.1%) had at least one
positive lymph node on ﬁnal histopathology. We had 31
cases of parotid gland and 5 cases of submandibular gland
malignancy. Among those with parotid gland involvement,
19 cases (52.8%) underwent parotidectomy along with
neck dissection and 11 cases (30.7%) only underwent
parotidectomy. Majority of the patients 21 (58.3%) received
adjuvant radiotherapy whereas only 3 cases received
chemoradiotherapy.
The mean survival time of the patients are presented in
Vol. 70, No. 9, September 2020

Gender
Site

Node positivity
Radiotherapy
Chemotherapy

Male
Female
Parotid gland
Submandibular gland
Positive
Negative
Yes
No
Yes
No
Yes
No

209.59
122.79
157.28
55.4
105.56
155.76
54.52
100.13*
66.31*
97.73*
43.5
83.76*

Log rank test
(p-value)
0.36
0.35
0.21
0.001
0.06
0.03

*Restricted Mean (last observation censored)

Figure-1: Kaplan Meier curves showing the mean survival time (months) of patients
stratified on grade of tumor.

Figure-2: Kaplan Meier curves showing the mean survival time of patients in months
stratified on node positivity.

Table 2. Log rank test was used to test the signiﬁcance of
survival time in stratifying the variables. The signiﬁcant
prognostic factors were Node positivity (p=0.001),
radiotherapy (p=0.06) and chemotherapy (p=0.03).
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Due to sparse data, further analysis (univariate and
multivariable analysis) was not done.
Kaplan Meier curves graphically show the mean survival
time of patients stratiﬁed by grade of tumour and node
positivity. (Figure 1,2)

Conclusion
Grade of the tumour, positive lymph node status and
adjuvant therapy are the prognostic factors that
signiﬁcantly alter the survival time in our cohort of patients
with salivary gland cancer. Patients with high grade tumour
and positive neck nodes require aggressive adjuvant
treatment and close follow-ups.
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